Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

DataMeds AI

Tracked across 10 events · 75 articles · First seen Jun 26, 2026 · Last active Sep 21, 2026

Sentiment
22
Attention
4
Events
10
Relationships
8
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 20
Business
Impact: DataMeds AI is the central company launching the Health Lives Here initiative, which could enhance its market position in health IT and data monetization, though execution risks remain.
Aug 05, 2026 · 6 articles
1 20
Business
Impact: DataMeds AI is the issuer of the meme coin dividend, which could boost investor interest but also raises concerns about the company's use of resources and potential regulatory issues.
Jul 27, 2026 · 8 articles
2 10
Business
Impact: DataMeds AI is the parent company executing the rebranding and strategic initiatives, which may strengthen its healthcare services portfolio and market positioning.
Aug 10, 2026 · 13 articles
1 20
Business
Impact: DataMeds AI is the primary company launching Galectovid, which could drive revenue and strengthen its product portfolio. The launch may positively affect its stock price and market perception.
Aug 27, 2026 · 10 articles
1 20
Business
DataMeds AI, Inc. (NASDAQ:MEDS) and Tollo Health, LLC announced a joint partnership with the NFL Players Association through its Alumni Health subsidiary. The collaboration aims to provide underserved and rural communities with access to telehealth…
Impact: DataMeds AI is a primary partner, leveraging its technology and pharmacy network to launch the Health Lives Here platform, potentially boosting its business and stock.
Sep 08, 2026 · 6 articles
2 60
Business
DataMeds AI, Inc. (NASDAQ:MEDS) completed the acquisition of Helomics Corporation, an artificial intelligence cancer diagnostics laboratory business, from Computex Inc. (NASDAQ:AGPU) for a total purchase value of $1.5 million. The consideration consisted of common shares…
Impact: DataMEDS acquired Helomics for $1.5 million, expanding into cancer diagnostics and treatment. The acquisition and subsequent stock surge reflect positive market reception and strategic growth.
Sep 15, 2026 · 7 articles
1 25
Business
DataMeds AI (NASDAQ:MEDS), a Tampa-based health IT and healthcare company formerly known as Wellgistics Health, Inc., announced on September 18, 2026 that it has settled litigation tied to outstanding debt and receivables arising from the…
Impact: The settling party; extinguishes about $19 million in liabilities for $450,000 cash and 364,099 retired shares, strengthening its balance sheet and reducing litigation overhang.
Sep 18, 2026 · 7 articles
1 10
Business
DataMeds AI, Inc. (NASDAQ:MEDS), a Tampa-based Health IT company formerly known as Wellgistics, Inc., announced on September 21, 2026 the launch of its new corporate website, www.DataMedsAI.com. The company said the updated site aligns with…
Impact: DataMeds AI is the central actor, launching its new corporate website as part of rebranding and marketing efforts following its Helomics acquisition and litigation settlement. The update is largely promotional and does not materially change its financial position.
Sep 21, 2026 · 6 articles
4 20
Business
Impact: DataMeds AI is the proposed new corporate name for Wellgistics and represents the focus on integrating technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units.
Jun 26, 2026 · 6 articles
3 20
Business
Impact: DataMeds AI is the proposed new name for Wellgistics, reflecting a strategic shift towards a patient-centric health technology ecosystem. The warrant exercise by executives supports this new direction.
Jun 30, 2026 · 6 articles
Gerald Commissiong ↔ DataMeds AI
Gerald Commissiong co-ceo ↔ DataMeds AI Gerald Commissiong serves as the Interim Co-CEO of DataMeds AI, where he is acti
Corexa Health parent ↔ DataMeds AI DataMeds AI is the parent company that established Corexa Health as its pharmacy
Tollo Health acquirer ↔ DataMeds AI DataMeds AI has entered into a non-binding letter of intent to acquire a control
Corexa Health subsidiary ↔ DataMeds AI Corexa Health is the newly rebranded pharmacy-focused division of DataMeds AI, h
Tollo Health target ↔ DataMeds AI Tollo Health is the target of a proposed acquisition by DataMeds AI, which has a
Datavault AI ↔ DataMeds AI
Datavault AI ↔ DataMeds AI
ERGEN INTELLIGENCE
Track DataMeds AI live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.